"Saidee is adept at designing indices for all kinds of scenarios and uses," said Patrick Shaddow, CEO of Syntax. "Saidee is destined to become an essential support tool for RIAs, financial advisors, ...
Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...